Can Operational Resiliency Protect HCA's Long-Term Profitability?

HCA Healthcare, Inc. HCA faces a significant earnings headwind from health insurance exchange disenrollment, with the company estimating a $1.0-$1.2 billion unfavorable impact in 2026. At the same time, professional fees and other operating costs remain elevated. Against this backdrop, its multi-year resiliency program is becoming an important tool for strengthening financial performance.

Same-facility cost per equivalent admission was essentially flat year over year in the second quarter and improved 1.4% sequentially. The combined cost of salaries and benefits, supplies, and other operating expenses per adjusted admission was only flat to slightly higher than a year earlier. This suggests that HCA is gaining greater control over its underlying cost base, even as the operating environment remains challenging. The progress is important because better cost control can help HCA offset inflation and protect profitability.

HCA’s investments in digital transformation, global capabilities and expanded shared services could support recurring productivity gains and reduce reliance on temporary cost-cutting measures. That matters as elective surgery remains pressured by affordability concerns, while changes in payer mix weigh on earnings.

If these initiatives consistently deliver productivity improvements, the resiliency program transitions from an emergency buffer into a durable margin driver. The ability to keep unit costs in check while maintaining volume growth could become an increasingly important contributor to HCA’s targeted 4-6% long-term adjusted EBITDA growth.

How Do Peers Compare?

HCA is not alone in prioritizing operational efficiency. Medical peers such as Tenet Healthcare Corporation THC and Universal Health Services, Inc. UHS are also pursuing efficiency initiatives and expanding outpatient capabilities to drive growth and profitability.

Tenet Healthcare has strengthened profitability through operational discipline and a growing ambulatory-care platform. THC’s focus on efficiency, higher-acuity care and portfolio optimization strengthens earnings resilience and supports healthier margins.

Universal Health continues to emphasize disciplined cost management and operational efficiency across its hospital and behavioral-health businesses. UHS’ ability to control expenses while sustaining earnings growth makes its margin resilience an important factor for investors tracking healthcare operators.

HCA’s Price Performance, Valuation & Estimates

Shares of HCA Healthcare have gained 3.8% over the past year compared with the industry's 12.8% growth over the same period.

Image Source: Zacks Investment Research

From a valuation standpoint, HCA trades at a forward price-to-earnings ratio of 13.44X, down from the industry average of 16.69X. HCA carries a Value Score of A.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for HCA’s 2026 earnings is pegged at $29.42 per share, implying a 4.3% jump from the year-ago period’s level.

Image Source: Zacks Investment Research

HCA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research